The key focus of this research has been outlined as below:
  1. Technology benchmarking and roadmap, market trends, capabilities, and applications targeted: Build a robust strategy by defining the universe of preclinical disease models opportunities and setting key priorities
  2. Stakeholder activities, influence, industry initiatives: Evaluate opportunities by describing the main participants in the industry, analyzing potential outcomes and generating competitive intelligence
  3. Investment environment and funding support: Support execution by connecting specific strategies with milestones, targets, owners, and deadlines based in funding and investments
  4. Industry evolution and business analytics: Preclinical disease models overall industry evolution and business models